NCT05829850View on ClinicalTrials.gov

An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 29, 2021

Primary Completion Date

January 9, 2023

Study Completion Date

January 9, 2023

Conditions
Osteo Arthritis Knee
Interventions
DEVICE

SYNOLIS VA 40/80

Three 2mL injections of SYNOLIS VA 40/80, one week apart

Trial Locations (3)

09-038

SPORTO oddzial na ulicy Miedzianej, Lodz

91-603

SPORTO oddzial na ulicy Książka (2nd site location), Lodz

02-757

Carolina Medical Center, Warsaw

Sponsors

Collaborators (1)

Noblewell
All Listed Sponsors
collaborator

Noblewell

INDUSTRY

lead

Aptissen SA

INDUSTRY

NCT05829850 - An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis | Biotech Hunter | Biotech Hunter